Research programme: DARPin targeted radioligand therapeutics - POINT Biopharma
Alternative Names: DARPin conjugated radioligands; DARPin-targeted radioligands; Radio-DARPinsLatest Information Update: 01 Jan 2024
At a glance
- Originator POINT Biopharma
- Class Antineoplastics; Drug conjugates; Proteins; Radioisotopes; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Cancer